Ganesh Kumar Barik, PhD (@itsme_gkb) 's Twitter Profile
Ganesh Kumar Barik, PhD

@itsme_gkb

Postdoc at Dana Farber Cancer Institute, Harvard Medical School, Interested in studying Cancer in depth, ERB Member@TCRT Journal, Nature Admirer...

ID: 1429141898371891201

calendar_today21-08-2021 18:02:56

2,2K Tweet

272 Followers

578 Following

Technology in Cancer Research & Treatment (IF 2.7) (@tcrt_cancer) 's Twitter Profile Photo

Join TCRT as a Section Editor! Make an impact in Cancer Biology, Detection, Diagnosis & Treatment. 🌟 IF 2.8 | Q2 Oncology | 600K+ downloads/year |500+ Board members Read more: bit.ly/4lBVOn9 Apply here: bit.ly/4nu0eye Technology in Cancer Research & Treatment journal Sage Journals #Oncology

Journal for ImmunoTherapy of Cancer (@jitcancer) 's Twitter Profile Photo

New #JITC article: ANV600 is a novel PD-1 targeted IL-2Rβγ agonist that selectively expands tumor antigen-specific T cells and potentiates PD-1 checkpoint inhibitor therapy bit.ly/4eVYBpa

New #JITC article: ANV600 is a novel PD-1 targeted IL-2Rβγ agonist that selectively expands tumor antigen-specific T cells and potentiates PD-1 checkpoint inhibitor therapy bit.ly/4eVYBpa
Katherine A Donovan (@kdonovan1008) 's Twitter Profile Photo

Our proteomics group is looking for a Scientist  who is excited to push the boundaries of chemoproteomics and interactomics at Dana‑Farber! Apply at the link or message me with questions! careers.dana-farber.org/job/11894/scie…

Waggoner Lab (@labwaggoner) 's Twitter Profile Photo

High A. finegoldii abundance is associated with improved anti-PD1 immunotherapy response in solid tumors (and models) via TLR2-NF-κB-CXCL16 signaling to boost CXCR6 immunity Cancer Cell cell.com/cancer-cell/fu…

High A. finegoldii abundance is associated with improved anti-PD1 immunotherapy response in solid tumors (and models) via TLR2-NF-κB-CXCL16 signaling to boost CXCR6 immunity <a href="/Cancer_Cell/">Cancer Cell</a> 
cell.com/cancer-cell/fu…
Pravat Kumar Parida (@p_k_parida) 's Twitter Profile Photo

It was a great experience co-writing with Dr. Srinivas Malladi (Malladi Lab - UTSW) on this comprehensive review on metabolic adaptations of brain metastasis published in Nature Reviews Cancer (bit.ly/44KqhtS). Many thanks to IISER Berhampur and Anusandhan National Research Foundation for their support.

Jen Heemstra (@jenheemstra) 's Twitter Profile Photo

First copies of my book are here!! As a new faculty member, I realized that in addition to my research job, I also had a leadership job…and I wasn’t prepared for that. This book is the guide I wish I’d had then, with the goal of helping others now.   jenheemstra.com/book

First copies of my book are here!! As a new faculty member, I realized that in addition to my research job, I also had a leadership job…and I wasn’t prepared for that. 

This book is the guide I wish I’d had then, with the goal of helping others now.
 
jenheemstra.com/book
Sanjeev Varshney (@skvdst) 's Twitter Profile Photo

Radcliffe Fellowship 2026-2027 by Harvard Radcliffe Institute to avail fellowship during September 2026 - May 2027 in Humanities, Social Sciences, and Creative Arts Science, Engineering, and Mathematics at radcliffe.onlineapplicationportal.com/misc/faq/progr… Apply by 11 Sep for Humanities & 30 Sep for STEM

Radcliffe Fellowship 2026-2027 by Harvard Radcliffe Institute to avail fellowship during September 2026 - May 2027 in 
Humanities, Social Sciences, and Creative Arts
Science, Engineering, and Mathematics
at radcliffe.onlineapplicationportal.com/misc/faq/progr…
Apply by 11 Sep for Humanities &amp; 30 Sep for STEM
Peter Adams🇪🇺🇺🇳 (@adamsbioaging) 's Twitter Profile Photo

UC Irvine is recruiting! Tenure-track faculty position, translational research in cancer biology, Otolaryngology - HNS & Anatomy/Neurobiology (Application due date: 08/29/2025). recruit.ap.uci.edu/JPF09682 I am always impressed by the science on my visits to UCI.

Journal for ImmunoTherapy of Cancer (@jitcancer) 's Twitter Profile Photo

New #JITC article: Anti-galectin-9 therapy synergizes with EGFR inhibition to reprogram the tumor microenvironment and overcome immune evasion bit.ly/4lBt5zj

New #JITC article: Anti-galectin-9 therapy synergizes with EGFR inhibition to reprogram the tumor microenvironment and overcome immune evasion bit.ly/4lBt5zj
Wantong Yao (@wantong_yao) 's Twitter Profile Photo

Excited to share our new study in Cell Reports Medicine uncovering YAP1-SDC1-multiple RTKs activation promotes resistance to KRAS inhibition. Grateful for supports from NIH PanCAN American Cancer Society MD Anderson Cancer Center cell.com/cell-reports-m…

Antonio Santinha (@antoniosantinha) 's Twitter Profile Photo

In vivo CRISPR screens offer a unique way to study gene function at scale🐁. In our new Nature Reviews Genetics article, Alessio Strano, Randall Platt, and I review current methods, experimental designs, and explore exciting future directions!nature.com/articles/s4157… ETH Zurich D-BSSE, ETH Zurich

Nature Reviews Cancer (@naturerevcancer) 's Twitter Profile Photo

#REVIEW 🚨 Parida & Malladi highlight tumour cell metabolic adaptations and crosstalk in the brain & discuss potential strategies to target these adaptations to improve outcomes for patients with brain metastasis. 📖 👇 bit.ly/44RMxC5

Debasish Paul (@paul6589) 's Twitter Profile Photo

Ever wonder how cells manage their energy for rapid growth? Our new nature paper reveals a key trick! We found how #mTOR signaling temporarily turns down a cell brake (APC/C) to create a vital burst of #glycolysis, essential for cell cycle entry. #Cancer #Cellcyle #metabolism

Verena Kohler (@_verenakohler) 's Twitter Profile Photo

This programme is ideal for professional development (incl a budget for that) and comes with a competitive package - make sure to check it out #MitoJobs #PostdocPosition #JobAd #WorkWithUs

Stephanie Ma (@stephaniema912) 's Twitter Profile Photo

Excited to share about our latest publication in Science Translational Medicine, showcasing findings on targeting AGPAT4 to overcome cancer cell plasticity, from a fruitful collaboration between our cancer biology and chemical biology teams. Science Translational Medicine

Excited to share about our latest publication in Science Translational Medicine, showcasing findings on targeting AGPAT4 to overcome cancer cell plasticity, from a fruitful collaboration between our cancer biology and chemical biology teams. 
<a href="/ScienceTM/">Science Translational Medicine</a>